Report #2896241

Received May 12, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NJ
Recovered: Recovered
Vaccinated: May 4, 2026
Onset: May 4, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	LA

Symptoms (1)

Heart rate increased

Symptom narrative

rapid heart beat; This non-serious case was reported by a consumer via call center representative and described the occurrence of heartbeats increased in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 04-MAY-2026 16:00, the patient received the 1st dose of Shingrix (left arm). On 04-MAY-2026 23:00, 7 hrs after receiving Shingrix, the patient experienced heartbeats increased (Verbatim: rapid heart beat). On 05-MAY-2026, the outcome of the heartbeats increased was resolved (duration 1 hr). It was unknown if the reporter considered the heartbeats increased to be related to Shingrix. It was unknown if the company considered the heartbeats increased to be related to Shingrix. Additional Information: GSK Receipt Date: 05-MAY-2026 The batch number was not provided upon follow up with the reporter.